Recent Articles from Business Wire

ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced an exclusive U.S. Development and Supply Agreement with Japan BCG Laboratory ("JBL"), the Tokyo-based developer and manufacturer of the Tokyo strain of BCG (Tokyo-172 BCG). The agreement provides ImmunityBio exclusive U.S. rights to develop, import, and commercialize intravesical Tokyo-172 BCG.
By ImmunityBio, Inc. · Via Business Wire · May 16, 2026
TetraMem Announces 22nm Multi-Level RRAM Analog In-Memory Computing SoC Milestone
TetraMem Inc., a Silicon Valley–based semiconductor company developing analog in-memory computing (IMC) solutions, today announced the successful tape-out, manufacturing, and initial silicon validation of its MLX200 platform, a 22nm multi-level RRAM-based analog IMC system-on-chip (SoC).
By TetraMem Inc. · Via Business Wire · May 16, 2026
Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), a global pharmaceutical company, today announced the launch of its generic Semaglutide Injection in Canada. Dr. Reddy’s is among the first companies to introduce a generic Semaglutide Injection in the Canadian market, following the Notice of Compliance (NOC) received from Health Canada on April 28th, 2026. Canada is the first G7 country to grant market authorization for Semaglutide Injection. The launch demonstrates Dr. Reddy’s readiness to ensure patient access following approval.
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer
AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been approved by the US Food and Drug Administration (FDA) for both the neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer based on results from the DESTINY-Breast11 and DESTINY-Breast05 Phase III trials, respectively.
By AstraZeneca · Via Business Wire · May 15, 2026
SolidProfessor Launches New Live, Instructor-Led Training for Design, Engineering and Manufacturing Teams
SolidProfessor announces SolidProfessor Live, a new offering of live, instructor-led training, to help design, engineering and manufacturing teams build skills, bridge knowledge gaps and get more value from the software they use every day.
By SolidProfessor · Via Business Wire · May 15, 2026
Starbucks Corporation Announces Early Results and Upsizing of its Tender Offers for Eight Series of Notes
Starbucks Corporation (Nasdaq: SBUX) (“Starbucks,” “we,” “us” or the “Company”) today announced the early results of its previously announced tender offers to purchase (each offer a “Tender Offer” and collectively, the “Tender Offers”) for cash the notes of the series listed in the table below (collectively, the “Notes”). The Tender Offers were made pursuant to the Offer to Purchase, dated May 4, 2026 (the “Offer to Purchase”), which sets forth a more comprehensive description of the terms and conditions of the Tender Offers. Capitalized terms used but not defined in this announcement have the meanings given to them in the Offer to Purchase.
By Starbucks Corporation · Via Business Wire · May 15, 2026
Metropolitan Issues Statement on Increased State Water Project Allocation
Metropolitan Water District General Manager Shivaji Deshmukh issues the following statement on the California Department of Water Resources’ increase of the State Water Project allocation to 45%:
ARMSTRONG WORLD INDUSTRIES, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
The law firm of Kirby McInerney LLP is investigating potential claims against Armstrong World Industries, Inc. (“Armstrong World” or the “Company”) (NYSE:AWI). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
By Kirby McInerney LLP · Via Business Wire · May 15, 2026
BLACK ROCK COFFEE BAR, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
The law firm of Kirby McInerney LLP is investigating potential claims against Black Rock Coffee Bar, Inc. (“Black Rock Coffee” or the “Company”) (NASDAQ:BRCB). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
By Kirby McInerney LLP · Via Business Wire · May 15, 2026
Rosen Law Firm Encourages Cencora, Inc. Investors to Inquire About Securities Class Action Investigation – COR
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cencora, Inc. (NYSE: COR) resulting from allegations that Cencora may have issued materially misleading business information to the investing public.
By The Rosen Law Firm, P.A. · Via Business Wire · May 15, 2026
KBRA Assigns Preliminary Ratings to GreenSky Home Improvement Issuer Trust 2026-REV1
KBRA assigns preliminary ratings to four classes of notes issued by GreenSky Home Improvement Issuer Trust 2026-REV1 ("GSKY 2026-REV1"), an asset-backed securitization collateralized by a pool of consumer loans used for home improvements.
INVESTOR ALERT: Securities Class Action Filed Against Phreesia, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) securities during the period of May 8, 2025 through March 30, 2026, inclusive (“the Class Period”).
By Kirby McInerney LLP · Via Business Wire · May 15, 2026
Faraday Future Announces $25 Million in New Financing, Demonstrating Institutional Investors' Confidence in the Company's Prospects; Recent Total of $70 Million in Financing to Sufficiently Support the Phase I Goals of Its Robotics Business Plan
Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI) ("FF", "Faraday Future", or the "Company"), a California-based global Embodied AI (EAI) ecosystem company, today announced it has entered into a Securities Purchase Agreement (the “Agreement”) with investors to issue convertible promissory notes in an aggregate principal amount of $25 million USD. The Company expects proceeds from the financing to accelerate the implementation of FF's EAI strategy to maintain FF's first-mover advantage as the first U.S. company to deliver both humanoid and bionic robots.
Sidecar Health Supports CMS Decision to Remove Network Requirement for ACA Exchange Plans
The Centers for Medicare and Medicaid Services (CMS) today removed the requirement that health plans offered on the ACA exchanges operate with a provider network. The decision opens the individual market to competition from network-free insurance models.
By Sidecar Health · Via Business Wire · May 15, 2026
Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer
Enhertu® (fam-trastuzumab deruxtecan-nxki) has been approved by the U.S. Food and Drug Administration (FDA) for two new breast cancer indications in the neoadjuvant and adjuvant settings of patients with HER2 positive early breast cancer.
By Daiichi Sankyo · Via Business Wire · May 15, 2026
Liberty Broadband Corporation Declares Quarterly Cash Dividend on Series A Cumulative Redeemable Preferred Stock
Liberty Broadband Corporation (Nasdaq: LBRDA, LBRDK, LBRDP) today announced that its Board of Directors declared the regular quarterly cash dividend payable to holders of its Series A Cumulative Redeemable Preferred Stock (the “Preferred Stock”) (Nasdaq: LBRDP). The per share amount of the quarterly cash dividend will be $0.43750001, payable in cash on July 15, 2026 to holders of record of the Preferred Stock at the close of business on June 30, 2026 (the “Record Date”).
Cotchett, Pitre & McCarthy Announces Federal Court Grants Final Approval of “Historic” Discrimination Settlement with Wells Fargo
Cotchett, Pitre & McCarthy announces today, May 15, 2026, Judge Trina Thompson of the United States District Court in the Northern District of California granted final approval of the historic $110 million settlement reached in In re Wells Fargo & Co. Consolidated Derivative Shareholder Litigation, a seminal derivative lawsuit brought by Wells Fargo shareholders that essentially combined two cases into one, and alleged that the Bank’s Board of Directors breached their fiduciary duties with regard to Wells Fargo’s discriminatory hiring and lending practices.
By Cotchett, Pitre & McCarthy · Via Business Wire · May 15, 2026
Rosen Law Firm Encourages Option Care Health, Inc. Investors to Inquire About Securities Class Action Investigation – OPCH
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Option Care Health, Inc. (NASDAQ: OPCH) resulting from allegations that Option Care Health, Inc. may have issued materially misleading business information to the investing public.
By The Rosen Law Firm, P.A. · Via Business Wire · May 15, 2026
USA Compression Partners Announces 2025 K-3 Tax Package Availability
USA Compression Partners, LP (NYSE: USAC) (“USA Compression”) today announced that its 2025 Schedule K-3 reflecting items of international tax relevance is available online. Unitholders requiring this information may access their Schedule K-3 at taxpackagesupport.com/usac.
Boxlight Reports First Quarter 2026 Financial Results
Boxlight Corporation (Nasdaq: BOXL) (“Boxlight” or the “Company”), a leading provider of interactive technology solutions, today announced the Company’s financial results for the first quarter ended March 31, 2026.
By Boxlight Corporation · Via Business Wire · May 15, 2026
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance under the company’s Investigational New Drug application to proceed with a clinical study of its investigational UHeart™ derived from a pig with 10 gene edits. The study, known as EXPRESS, will enroll an initial cohort of up to two participants. United Therapeutics will provide the FDA with safety and efficacy data from the first UHeart xenotransplant recipient in the study before enrolling a second participant. Following FDA review of available safety and efficacy data from the initial two transplants, the study may then be further expanded, with the intent to support a Biologics License Application (BLA) with the FDA.
Energy Vault Holdings, Inc. Announces New Hire Awards Under NYSE Listing Rule 303A.08
Energy Vault Holdings, Inc. (“Energy Vault”) (NYSE: NRGV), a global energy storage company today announced that, effective on April 29, 2026, the Compensation Committee of Energy Vault’s Board of Directors granted to 6 new employees restricted stock unit and performance-based restricted stock unit awards covering an aggregate 2,350,000 shares of its common stock under the Energy Vault Holdings, Inc. 2022 Employment Inducement Award Plan (as amended and/or restated, the “Plan”). The awards were granted as awards material to new employees entering into employment with Energy Vault in accordance with New York Stock Exchange Listing Rule 303A.08.
By Energy Vault Holdings, Inc. · Via Business Wire · May 15, 2026
St. Jude Corvette Drive Marks 15 Years of Impact for Families Across U.S.
The annual St. Jude Corvette Drive raced into its 15th year as a fleet of more than 140 Corvettes arrived in Memphis today, raising $750,315 this year for St. Jude Children’s Research Hospital®.
Gemini Space 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Gemini Space Station, Inc. - GEMI
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 18, 2026 to file lead plaintiff applications in a securities class action lawsuit against Gemini Space Station, Inc. (“Gemini” or the “Company”) (NasdaqGS: GEMI), if they purchased or otherwise acquired Gemini Class A common stock pursuant and/or traceable to the Company’s September 12, 2025 initial public offering (“IPO”), and/or Gemini securities between September 12, 2025 and February 17, 2026 (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
By Kahn Swick & Foti, LLC · Via Business Wire · May 15, 2026
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Humana Inc. (“Humana” or “the Company”) (NYSE: HUM).
By Kahn Swick & Foti, LLC · Via Business Wire · May 15, 2026
ERock Announces Public Filing of Registration Statement for Proposed Initial Public Offering
ERock, a recognized leader in reliable, large-scale onsite power and microgrid solutions, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of shares of its Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The Company intends to list its Class A common stock on the New York Stock Exchange under the ticker symbol "EROC”.
By ERock · Via Business Wire · May 15, 2026
Hagens Berman: Consumers Sue Amazon Alleging Unlawful Price Hikes to Cover Tariff Costs
A consumer-protection lawsuit from Seattle-based law firm Hagens Berman accuses Amazon.com of collecting funds from millions of its customers in response to since invalidated tariffs, passing the buck on rising costs through higher prices.
By Hagens Berman · Via Business Wire · May 15, 2026
Globalstar Announces an Update to the HIBLEO-4 Satellite Replenishment Launch
Globalstar (NASDAQ: GSAT), a next-generation telecommunications infrastructure and technology provider, today announced that the planned May 17 launch of its HIBLEO-4 replenishment satellites with SpaceX has been postponed to allow more time for Globalstar teams to prepare the satellites for launch. A new launch date will be shared once confirmed.
By Globalstar, Inc.   · Via Business Wire · May 15, 2026
Securities Fraud Investigation Into Claritev Corporation (CTEV) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV) on behalf of investors concerning the Company’s possible violations of federal securities laws.
OFS Credit Company Announces Preliminary Estimates of Certain Financial Results for its Second Fiscal Quarter 2026
OFS Credit Company, Inc. (Nasdaq: OCCI, OCCIM, OCCIN) (“OFS Credit”, the “Company”, “we”, “us” or “our”), an investment company that primarily invests in collateralized loan obligation (“CLO”) equity and debt securities, today announced preliminary estimates of certain financial results for the fiscal quarter ended April 30, 2026.
By OFS Credit Company, Inc. · Via Business Wire · May 15, 2026
RioCan Real Estate Investment Trust Announces May 2026 Distribution
RioCan Real Estate Investment Trust (“RioCan”) (TSX: REI.UN) today announced a distribution of 9.65 cents per unit for the month of May. The distribution will be payable on June 5, 2026, to unitholders of record as at May 29, 2026.
Capstone Holding Corp. Provides Filing Timeline for Q1 2026 Results
Capstone Holding Corp. (NASDAQ: CAPS), a tech-enabled building products distribution platform, today announced that it will delay the filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, to allow additional time to finalize its quarterly financial statements and complete the related interim review. The Company currently expects to file the Form 10-Q and publish related investor materials no later than Wednesday, May 20, 2026.
By Capstone Holding Corp. · Via Business Wire · May 15, 2026
Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) expects to release its financial results for the quarter and fiscal year ended March 31, 2026 before financial markets open on June 15, 2026. The Company also announced it plans to file restated financial results for the fiscal years ended March 31, 2025 and March 31, 2024 and to certain of the interim periods therein (the “Refiling”), in conjunction with its filing of financial results for the year ended March 31, 2026 on June 15, 2026, as further described below and in the Company’s material change report and the Company’s Current Report on Form 8-K each dated May 15, 2026.
By Canopy Growth Corporation · Via Business Wire · May 15, 2026
Granite REIT Declares Distribution for May 2026
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN) announced today that its board of trustees has declared a distribution of CDN $0.2958 per unit for the month of May 2026. The distribution will be paid by Granite on June 15, 2026 to unitholders of record at the close of trading on May 29, 2026.
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Securities Fraud Investigation Into Zoetis Inc. (ZTS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Brad Caldwell Appointed CEO of Optivate to Succeed Founder
Optivate, a leading provider of specialty-built software and solutions for ophthalmology practices, today announced the appointment of Brad Caldwell as Chief Executive Officer. Abdiel Marin, the company’s Founder and CEO, will transition to a role as an advisor and remain on the Board of Directors as the company enters its next phase of growth.
By Optivate · Via Business Wire · May 15, 2026
Natuzzi Filed Its Annual Report on Form 20-F With the SEC
Natuzzi S.p.A. (NYSE: NTZ) (“Natuzzi” or the “Company”) announced today that it filed its annual report on Form 20-F (the “Annual Report”) for the fiscal year ended on December 31, 2025, with the U.S. Securities and Exchange Commission (“SEC”). The Annual Report is available on the Company’s website www.natuzzi.com within the Investor Relations page (https://www.natuzzigroup.com/en-EN/ir/investors.html), or under the “SEC Filings” section.
By Natuzzi S.p.A. · Via Business Wire · May 15, 2026
Sharon AI Reports First Quarter 2026 Results
Today, SharonAI Holdings Inc. (NASDAQ:SHAZ) and its subsidiaries (“Sharon AI” or “the Company”), a leading Australian Neocloud, announced the release of its financial and operational results for the first quarter of 2026.
By SharonAI Holdings Inc. · Via Business Wire · May 15, 2026
Natuzzi Announces Financial Results for the Fourth Quarter of 2025
Natuzzi S.p.A. (NYSE: NTZ) (“we”, “Natuzzi” or the “Company” and, together with its subsidiaries, the “Group”), one of the most renowned brands in the production and distribution of design and luxury furniture, today reports its unaudited financial information for the fourth quarter ended December 31, 2025.
By Natuzzi S.p.A. · Via Business Wire · May 15, 2026
KBRA Assigns AAA Rating to State of Connecticut Special Tax Obligation Refunding Bonds, Transportation Infrastructure Purposes, 2026 Series A; Affirms Rating for Parity Bonds
KBRA assigns a long-term rating of AAA to the State of Connecticut Special Tax Obligation Refunding Bonds, Transportation Infrastructure Purposes, 2026 Series A and affirms the AAA long-term rating for outstanding Special Tax Obligation Bonds, Transportation Infrastructure Purposes. The rating Outlook is Stable.
Morgan Stanley Declares Dividends on Its Preferred Stock
Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues:
By Morgan Stanley · Via Business Wire · May 15, 2026
State Street Corporation 2026 Annual Meeting of Shareholders
As previously announced, State Street Corporation (NYSE:STT) will hold the 2026 Annual Meeting of Shareholders on Wednesday, May 20, 2026 at 9:00 a.m. ET. The Annual Meeting of Shareholders will be conducted online via live audio webcast at www.virtualshareholdermeeting.com/STT2026. State Street’s Chairman and Chief Executive Officer, Ronald P. O’Hanley, will provide brief remarks and respond to shareholder submitted questions.
By State Street Corporation · Via Business Wire · May 15, 2026
Cathay General Bancorp Declares $0.38 Per Share Dividend
Cathay General Bancorp (Nasdaq: CATY) announced that its Board of Directors declared a cash dividend of thirty-eight cents per common share, payable on June 9, 2026, to stockholders of record at the close of business on May 28, 2026.
By Cathay General Bancorp · Via Business Wire · May 15, 2026
Teleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 30, 2026, to shareholders of record at the close of business on May 25, 2026.
By Teleflex Incorporated · Via Business Wire · May 15, 2026
Materion Corporation to Participate in KeyBanc’s Industrials & Basic Materials Conference on May 28
Materion Corporation (NYSE: MTRN) will participate in the KeyBanc Industrials & Basic Materials Conference on May 28, 2026. Jugal Vijayvargiya, President and Chief Executive Officer and Shelly Chadwick, Vice President, Finance and Chief Financial Officer, will be available for one-on-one meetings with investors throughout the day.
By Materion Corporation · Via Business Wire · May 15, 2026
JPMorganChase Declares Preferred Stock Dividends
JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) has declared dividends on the outstanding shares of the Firm’s Series II, OO and PP preferred stock. Information can be found on the Firm’s Investor Relations website at https://www.jpmorganchase.com/ir/news.
By JPMorgan Chase & Co. · Via Business Wire · May 15, 2026
Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026, in New York, NY.
By Novanta Inc. · Via Business Wire · May 15, 2026
Kennedy Wilson Announces Launch of Tender Offer for Any and All of Its Outstanding 5.000% Senior Notes Due 2031 and Issuance of Notices of Redemption for its 4.750% Senior Notes Due 2029 and its 4.750% Senior Notes Due 2030
Kennedy-Wilson, Inc. (the “Issuer”), a wholly-owned subsidiary of global real estate investment company Kennedy-Wilson Holdings, Inc. (NYSE: KW) (the “Company” or “Kennedy Wilson”), today announced that it has commenced an offer to purchase for cash (the “Offer”) any and all of its outstanding 5.000% Senior Notes due 2031 (the “Notes”), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated May 15, 2026, as it may be amended or supplemented from time to time (the “Offer to Purchase”). The Offer is being made pursuant to the Fundamental Change Offer provisions of the indenture governing the Notes (the “Indenture”) in connection with the proposed acquisition of the Company pursuant to an Agreement and Plan of Merger (the “Merger Agreement”), dated as of February 16, 2026, as amended on March 15, 2026, by and among the Company, Kona Bidco, LLC and Kona Merger Subsidiary, Inc. (“Merger Sub”), an entity affiliated with a consortium led by William McMorrow, Chairman and Chief Executive Officer of the Company, and certain other senior executives of the Company, and including Fairfax Financial Holdings Limited (“Fairfax”) (collectively, the “Consortium”), pursuant to which, subject to the satisfaction of customary closing conditions, Merger Sub would merge with and into the Company, and the Company would continue as the surviving corporation (the “Merger”). The consummation of the Merger is expected to constitute a Fundamental Change under the Indenture.
By Kennedy-Wilson, Inc. · Via Business Wire · May 15, 2026
Sugar Foods Issues Recall of Specific Lots of Kroger Homestyle Cheese Garlic Croutons Due to Possible Health Risk
Sugar Foods LLC is recalling certain lots of Kroger Homestyle Cheese Garlic Croutons, 5oz pouches, UPC 0 11110 81353 4 due to the potential for Salmonella contamination associated with milk powder used as an ingredient in the product. Salmonella is an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella may experience fever, diarrhea (which may be bloody), nausea, vomiting, and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis, and arthritis.
By Sugar Foods LLC · Via Business Wire · May 15, 2026
Retractable Technologies, Inc. Results for the Period Ended March 31, 2026
Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.2 million for the first three months of 2026 and an operating loss of $6.2 million for the period, as compared to total net sales for the same period last year of $8.3 million and an operating loss of $4.7 million.
Driven Brands Holdings Inc. to Host 2025 Fourth Quarter and Year-End Earnings Call on May 19, 2026
Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven Brands” or the “Company”) will release its financial results for the fourth quarter and fiscal year ended December 27, 2025, before the market opens on May 19, 2026. Following the release, management will host a conference call at 8:30 a.m. ET to review the Company’s financial and operating performance.
By Driven Brands · Via Business Wire · May 15, 2026
Westlake Corporation Declares Quarterly Dividend
The Board of Directors of Westlake Corporation (NYSE: WLK) today declared a regular dividend distribution of $0.53 per share for the first quarter of 2026. This dividend will be payable on June 11, 2026 to stockholders of record on May 27, 2026.
By Westlake Corporation · Via Business Wire · May 15, 2026
Xylem Declares Second Quarter Dividend of 43 Cents per Share
The Board of Directors of Xylem Inc. (NYSE: XYL), has declared a second quarter dividend of $0.43 per share payable on June 25, 2026, to shareholders on record as of May 28, 2026.
By Xylem Inc. · Via Business Wire · May 15, 2026
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 38,481 shares of its common stock to six newly hired employees, consisting of inducement stock options to purchase an aggregate of 12,061 shares of common stock and inducement restricted stock units, covering an aggregate of 26,420 shares of its common stock.
By Scholar Rock, Inc. · Via Business Wire · May 15, 2026
MetLife Declares Second Quarter 2026 Preferred Stock Dividends
MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends:
By MetLife, Inc. · Via Business Wire · May 15, 2026
Rayonier Announces Second Quarter 2026 Dividend
Rayonier Inc. (NYSE:RYN) announced today that the Company’s board of directors has declared a second quarter cash dividend of $0.26 per common share. The dividend is payable on June 30, 2026, to shareholders of record on June 16, 2026.
By Rayonier · Via Business Wire · May 15, 2026
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of Phase 1b data evaluating botensilimab (BOT), an Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), an anti-PD-1 antibody, in patients with treatment-refractory hepatocellular carcinoma (HCC) who had progressed following prior immunotherapy. The manuscript, titled “A phase 1b study of botensilimab and balstilimab in treatment-refractory hepatocellular carcinoma,” was published in Liver Cancer and is available at DOI: 10.1159/000551630.
By Agenus Inc. · Via Business Wire · May 15, 2026
Voya Equity Closed End Funds Declare Distributions
Voya Investment Management, the asset management business of Voya Financial, Inc. (NYSE: VOYA), announced today the distributions on the common shares of five of its closed-end funds: Voya Global Advantage and Premium Opportunity Fund (NYSE: IGA), Voya Global Equity Dividend and Premium Opportunity Fund (NYSE: IGD), Voya Infrastructure, Industrials and Materials Fund (NYSE: IDE), Voya Asia Pacific High Dividend Equity Income Fund (NYSE: IAE), and Voya Emerging Markets High Dividend Equity Fund (NYSE: IHD).
By Voya Financial, Inc. · Via Business Wire · May 15, 2026
First Colony Mortgage Becomes One of the First Lenders in the Nation to Fully Deploy AI-Powered Mortgage Technology with Tidalwave
First Colony Mortgage (firstcolonymortgage.com) today announced it has become one of the first mortgage lenders in the country to fully deploy Tidalwave (Tidalwave.com), a next-generation AI-powered point-of-sale platform, across its entire loan officer and operations teams. The move marks a defining moment — not just for First Colony Mortgage, but for the mortgage industry as a whole.
By First Colony Mortgage · Via Business Wire · May 15, 2026
Novanta to Present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026, in New York, NY.
By Novanta Inc. · Via Business Wire · May 15, 2026
Skillz Reports First Quarter 2026 Results
Skillz Inc. (NYSE: SKLZ) (“Skillz” or the “Company”), the leading mobile games platform bringing fair competition to players worldwide, today reported unaudited financial results for the first quarter ended March 31, 2026.
By Skillz Inc. · Via Business Wire · May 15, 2026
AIR, the Global Leader in Flavored Shisha Molasses, Completes Business Combination and will Begin Trading on Nasdaq Stock Market
AIR Limited (“AIR” or the “Company”), the global leader in flavored shisha molasses and pioneer in advanced inhalation technologies, today announced the closing of its previously announced business combination with Cantor Equity Partners III (“CAEP”), which was approved by CAEP shareholders at an extraordinary general meeting on May 12, 2026.
By AIR Limited · Via Business Wire · May 15, 2026
Sunoco LP 2025 Schedule K-3s Now Available
Sunoco LP (NYSE: SUN) (“SUN” or the “Partnership”) today announced that its 2025 Schedule K-3 reflecting items of international tax relevance is available online. Unitholders requiring this information may access their Schedule K-3 at www.sunocolp.com in the investor relations section of the website.
By Sunoco LP · Via Business Wire · May 15, 2026
Energy Transfer Schedule K-3s for 2025 Now Available
Energy Transfer LP (NYSE: ET) today announced that its 2025 Schedule K-3s reflecting items of international tax relevance are available online. Unitholders requiring this information may access their Schedule K-3 at energytransfer.com in the investor relations section of the website.
By Energy Transfer LP · Via Business Wire · May 15, 2026
Sensata Technologies Holding plc Announces Cash Tender Offers by Certain Subsidiaries for Senior Notes
Sensata Technologies Holding plc (NYSE: ST) (“Sensata”) announced today that Sensata Technologies B.V. and Sensata Technologies, Inc., its indirect, wholly owned subsidiaries (each, an “Offeror” and collectively, the “Offerors”), have commenced cash tender offers (each, individually with respect to a series of Notes, a “Tender Offer” with respect to such series, and collectively, the “Tender Offers”) to purchase up to $350,000,000 in total cash consideration payable, excluding the applicable Accrued Interest (as defined below) (the “Maximum Tender Offer Amount”) of the applicable Offeror’s senior notes, as identified in the table below (collectively, the “Notes”).
Waste Connections Annual Shareholders Meeting Results
Waste Connections, Inc. (TSX/NYSE: WCN) (“Waste Connections” or the “Company”) today announced the results of its annual meeting of shareholders (the “Meeting”). All eight director nominees in the Company’s 2026 management information circular and proxy statement (the “Proxy Statement”) were nominated and elected as directors of the Company at the Meeting. Each director will serve until the close of the next annual meeting of shareholders or until his or her earlier resignation, or his or her successor is duly elected or appointed.
By Waste Connections, Inc. · Via Business Wire · May 15, 2026
VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION
Voya Global Advantage and Premium Opportunity Fund (NYSE: IGA) and Voya Infrastructure, Industrials and Materials Fund (NYSE: IDE) (the “Funds”) today announced important information concerning the Funds’ distributions declared in April 2026. This press release is issued as required by the Funds’ Managed Distribution Plan (the “Plan") and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the May distribution. It is not determinative of the tax character of the Funds’ distributions for the 2026 calendar year. Shareholders should note that the Funds’ total regular distribution amount is subject to change as a result of market conditions or other factors.
By Voya Financial, Inc. · Via Business Wire · May 15, 2026
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced that on May 14, 2026 (Grant Date), the Compensation Committee of the Company’s Board of Directors granted an inducement award consisting of a non-qualified stock option to purchase 51,000 shares of Class A common stock to one new non-executive employee under the Company’s 2026 Employment Inducement Equity Incentive Plan. The award was granted as an inducement material to the new employee’s employment in accordance with Nasdaq Listing Rule 5635(c)(4).
Lantern Pharma Reports First Quarter 2026 Financial Results and Provides Business Updates
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company leveraging its proprietary RADR® artificial intelligence (AI) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced operational highlights and financial results for the first quarter ended March 31, 2026, and provided an update on its portfolio of AI-driven drug candidates and AI platforms.
By Lantern Pharma Inc. · Via Business Wire · May 15, 2026
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as material inducements to four individuals whose employment commenced in either March 2026 or April 2026.
By Delcath Systems, Inc. · Via Business Wire · May 15, 2026
Knightscope Q1 Revenue Up 106% to $6M
Knightscope, Inc. (NASDAQ: KSCP), a managed service provider building the nation’s first Autonomous Security Force, today reported financial results for the first quarter ended March 31, 2026.
By Knightscope, Inc. · Via Business Wire · May 15, 2026
C-PACE Vermont Clears Final Legislative Hurdle. Commercial Clean Energy Financing Tool Now Heads to Governor’s Desk.
After years of bipartisan collaboration and practical refinement, Vermont’s Commercial Property Assessed Clean Energy (C-PACE) program is on the verge of becoming law. Sponsored by Sen. Thomas Chittenden and gaining strong bipartisan support, Senate bill S.138, originally introduced to expand property-assessed financing for energy efficiency, renewable energy, and resilience upgrades, has been successfully incorporated into the omnibus economic development bill S.327. On May 14, 2026, the Senate concurred with the House proposal of amendment, sending the measure to enrollment and the Governor’s desk for signature in the coming days.
By CounterpointeSRE · Via Business Wire · May 15, 2026
Emmaus Life Sciences Reports Quarterly Financial Results
Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three months ended March 31, 2026.
By Emmaus Life Sciences, Inc. · Via Business Wire · May 15, 2026